Sustained administration of furosemide during the neonatal period regulates KCC2/NKCC1 levels in the developing brain and induces behavioral abnormalities
Japan Society for Neonatal Health and Development 2025
発表形態
口頭発表(招待・特別)
発表開始年月
2025/11
発表終了年月
2025/11
概要
「Sustained administration of furosemide during the neonatal period regulates KCC2/NKCC1 levels in the developing brain and induces behavioral abnormalities」について、Japan Society for Neonatal Health and Development 2025において口頭発表(招待・特別)として実施・公表した業績。